000			01992 a2200505 4500
005			20250517032237.0
264		0	_c20160510
008			201605s 0 0 eng d
022			_a1538-8514
024	7		_a10.1158/1535-7163.MCT-15-0100 _2doi
040			_aNLM _beng _cNLM
100	1		_aTalekar, Meghna
245	0	0	_aCosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer. _h[electronic resource]
260			_bMolecular cancer therapeutics _cJul 2015
300			_a1521-31 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents, Phytogenic _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aDrug Resistance, Multiple _xdrug effects
650	0	4	_aDrug Resistance, Neoplasm _xdrug effects
650	0	4	_aFemale
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aHyaluronic Acid _xchemistry
650	0	4	_aMice, Nude
650	0	4	_aMicroscopy, Confocal
650	0	4	_aMicroscopy, Electron, Transmission
650	0	4	_aNanoparticles _xchemistry
650	0	4	_aOvarian Neoplasms _xgenetics
650	0	4	_aPaclitaxel _xpharmacology
650	0	4	_aPyruvate Kinase _xgenetics
650	0	4	_aRNA, Small Interfering _xchemistry
650	0	4	_aRNAi Therapeutics _xmethods
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aTissue Distribution
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aOuyang, Qijun
700	1		_aGoldberg, Michael S
700	1		_aAmiji, Mansoor M
773	0		_tMolecular cancer therapeutics _gvol. 14 _gno. 7 _gp. 1521-31
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-15-0100 _zAvailable from publisher's website
999			_c24891025 _d24891025